TNF and cancer: Although the major catabolic drivers of muscle wasting in cachectic patients are not fully characterized [10], a number of tumor-derived inflammatory cytokines have been shown to promote cancer cachexia, such as tumor necrosis factor α (TNFα) and interferon-γ (IFN- γ) [11].